Chase and Disney have loaded the Disney Inspire Visa Card with a mix of perks and bonus points that make it easy for Disney ...

Investment ​firm KKR is preparing OPI ‌nail polish owner Wella Company for an initial public ​offering in the U.S. as soon as this year that could value the global ‍beauty company at meaningfully more ...

A federal court ​judge in ‌Washington ‍in 2024 ⁠ruled Google has a monopoly in the online search business, ​but rejected the toughest remedies. Thirty-five states, in addition to the District of ...

Kaiser Permanente urged members on ‌Tuesday ​to get laboratory tests done ‌this week after unions representing pharmacy and lab workers filed to begin striking ​in Southern California on Monday and an ...

Feb 4 (Reuters) - New Zealand's Synlait ‌Milk ​said on Wednesday ‌it expects to post a loss ​for the first half of fiscal ...

Feb 3 (Reuters) - Nvidia ‌will ​consider investing ‌in OpenAI's next fundraising round ​and in the startup's eventual ‍IPO, CEO Jensen ​Huang told CNBC ​in ⁠an interview on Tuesday.

OpenAI launched a standalone app for Codex for Apple's macOS on Monday, aiming to compete more directly with tools such as ...

WEST PALM BEACH, Feb 3 (Reuters) - Billionaire investor Ken Griffin ‌said ​on Tuesday that he believed the U.S. ‌dollar had lost some of its luster with investors in the last 12 months.

WASHINGTON/HOUSTON, Feb 3 (Reuters) - ‌The U.S. government is working to ​issue as early as this week a general license ...

Felix-Antoine Vezina-Poirier, associate strategist at BCA in Montreal, said while Warsh has pointed to AI-driven productivity gains as a reason "not ​to worry about future inflation," higher ...

COPENHAGEN, Feb 3 (Reuters) - Wegovy maker Novo Nordisk warned on Tuesday ‌that ​profits and sales could drop ‌as much as 13% this year, the first declines in years, in a ​new setback for the obesity ...

The selloff comes as Wall Street is reassessing long-held expectations that the obesity drug market could hit $150 billion early next decade, as U.S. prices for GLP-1 treatments from Novo and Lilly ...